Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Cartilage Technologies, Inc.

This article was originally published in The Tan Sheet

Executive Summary

Cartilage Technologies, Inc.: Announces plans to distribute Cartilade shark cartilage via drug wholesalers and brokers. Morgan Sampson Pacific, Pinnacle Sales, Florida Marketing, Hynes Sales, Ed Hockfield Associates and Ken Madden Associates have come on board as brokers. Drug wholesaler Bergen Brunswig also has agreed to carry the product, CTI said, adding that it is in negotiations with McKesson, FoxMeyer, and Alco. Cartilade has been on shelves in some independent pharmacies and "most health food stores" for about five years, the company said. CTI and Bergen Brunswig plan "major promotions" beginning in August, when radio and print ads will tout Cartilade as an "ideal source of...dietary calcium and phosphorus" as well as an antigenesis inhibitor that "may alleviate the discomfort and reduced mobility associated with joint conditions"..

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS083917

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel